查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
重組蛋白全球市場規模、份額和行業趨勢分析報告：2022-2028 年各產品、最終用戶、應用和地區的展望和預測
市場調查報告書
商品編碼
1184285

重組蛋白全球市場規模、份額和行業趨勢分析報告：2022-2028 年各產品、最終用戶、應用和地區的展望和預測

Global Recombinant Proteins Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 283 Pages | 訂單完成後即時交付

價格

在預測期內，重組蛋白的全球市場規模預計將以 10.8% 的複合年增長率增長，到 2028 年將達到 26 億美元。

該業務的增長預計將受到肉芽腫病、血友病和硬化症等慢性病發病率增加的推動。 此外，重組蛋白產品的改進、對生物製劑和生物仿製藥的日益偏好以及其他原因都有助於行業擴張。 COVID-19 的爆發加劇了尋找 SARS-CoV2 病毒治療和診斷工具的競賽。

根據 Global Genes 的數據，全球有超過 4 億人患有罕見遺傳病。 這個數字突出了對治療、改善醫療保健環境和增加公眾對健康問題的了解的迫切需要。 藥物靶向機制的最新研究和知識對於生產藥物至關重要。

隊列計劃在多個地區創建了生物樣本庫，使研究人員能夠獲得高質量的樣本，這些樣本正在徹底改變治療工作。 這可能會導致更加強調識別各種疾病的生物標誌物。 例如，2022 年 8 月，FDA 批准 Ayvakit 用於治療晚期系統性肥大細胞增多症，這是一種罕見的血液疾病。

COVID-19 影響分析

對快速大規模開發 COVID-19 疫苗的需求，加上正在進行的商業製造活動，將對生物製品研究工作產生積極影響，從而推動行業擴大 COVID-19 大流行對蛋白質市場的擴張產生了有利影響。 鑑於 COVID 感染的傳播，可以開發結合不同佐劑和抗原亞基的重組蛋白疫苗，這些疫苗對 SARS-CoV-2 感染更有效，並且在中心很容易獲得。

市場增長因素

由於慢性病的增加，人們對定製藥物的興趣與日俱增

重組蛋白被認為是為數不多的治療慢性病的藥物之一，隨著慢性病的增多，對重組蛋白療法的需求也越來越大。 據 GLOBOCAN 估計，2020 年墨西哥將出現 195,499 例新癌症病例和 90,222 例癌症相關死亡病例。 一些生物技術，如疫苗、重組蛋白、細胞和基因療法，對於治療的個體化至關重要，因此需要納入個體化醫療的發展。

增加生物製品的研發

由於生物製劑研究和開發的增加，預計重組蛋白市場的需求將會增長。 由於研究週期長和法規滯後，研發行業傳統上需要大量資金。 研發支出佔全球支出的很大一部分。 各國政府認識到研發是國家發展、國際競爭力和公共利益的重要因素。 因此，研發資金和支出穩步增加。

市場約束

重組蛋白越來越便宜。

重組蛋白是使用實驗室培養的細胞製成的，這導致了它們的高成本。 據說佔製造成本 80% 的煉油也是一項主要支出。 價格侵蝕被定義為大量玩家進入特定市場，銷售沒有原創性的相同產品，並以價格合理但沒有創意的產品飽和市場。 價格侵蝕是指這些產品在市場上的價格不斷下降，從而減緩了市場擴張。

產品展望

按產品劃分，它分為生長因子和趨化因子、免疫反應蛋白、結構蛋白、膜蛋白、激□蛋白、調節蛋白、重組代謝□、粘附分子和受體以及其他重組蛋白。 到 2021 年，免疫反應蛋白預計將佔銷售額的很大一部分。 細胞因子是體內一組重要的蛋白質。 這些小蛋白質充當免疫系統的信使。 它充當免疫系統的通信網絡，並作為對威脅的反應而產生。 免疫系統細胞有時通過彼此直接接觸相互作用，但更常見的是通過分泌細胞因子，它們可以作用於附近或遠處的細胞。

應用展望

按應用分為藥物發現和市場開發、生物製藥生產、生物技術研究、學術研究、診斷和其他應用。 生物技術研究將在 2021 年佔據很大的收入份額。 重組蛋白有助於闡明生物的基本原理。 這些分子可用於定位和查明由特定基因編碼的蛋白質，以及其他基因在細胞信號傳導、代謝、生長、複製、死亡和翻譯中的作用。了解更多關於它們如何參與以下過程的信息、轉錄和蛋白質修飾。

最終用戶視角

基於最終用戶，重組蛋白市場細分為製藥和生物製藥行業、生物技術行業、學術研究機構、合同研究機構和其他最終用戶。 合同研究實驗室預計將在 2021 年佔市場收入的很大一部分。 研發行業對學術機構和公司之間的伙伴關係和合作的投資有所增加。 例如，輝瑞的治療創新中心 (CTI) 充當醫療保健系統利益相關者之間互動的論壇。

區域展望

按地區劃分，重組蛋白市場分為北美、歐洲、亞太地區和 LAMEA。 2021年重組蛋白的主要區域市場是北美。 慢性病和遺傳病的高患病率；研發資金；由於製藥業的大量存在以及分析儀器在藥物發現和研發中的應用，北美似乎在全球市場中佔有很大份額。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球重組蛋白市場，副產品
    • 全球重組蛋白市場，按最終用戶分類
    • 全球重組蛋白市場，按應用分類
    • 全球重組蛋白市場，按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章重組蛋白市場的發展戰略

第 4 章全球重組蛋白市場：按產品分類

  • 全球生長因子和趨化因子市場：按地區
  • 重組代謝□、粘附分子和受體的全球市場，按地區劃分
  • 按區域劃分的全球結構蛋白市場
  • 全球膜蛋白市場：按地區
  • 按地區分列的激□蛋白和調節蛋白的全球市場
  • 全球免疫反應蛋白市場，按地區劃分
  • 世界其他地區的世界市場

第 5 章全球重組蛋白市場：按最終用戶分類

  • 按地區劃分的全球製藥和生物製藥市場
  • 生物技術公司的全球市場，按地區劃分
  • 全球學術研究機構市場，按地區
  • 按地區劃分的合同研究機構全球市場
  • 世界其他地區的世界市場

第 6 章全球重組蛋白市場：按應用

  • 藥物發現和市場開發的全球市場：按地區
  • 全球學術研究市場：按地區
  • 全球生物製藥生產市場：按地區
  • 全球診斷市場：按地區
  • 全球生物技術研究市場：按地區
  • 全球各地區的其他市場

第 7 章：重組蛋白的全球市場：按地區分類

  • 北美
    • 按國家/地區劃分的北美重組蛋白市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲重組蛋白市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太地區重組蛋白市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 重組蛋白市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 拉美其他地區

第八章公司簡介

  • Bio-Techne Corporation
  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Bio-Rad laboratories, Inc.
  • Abcam plc
  • Genscript Biotech Corporation
  • Miltenyi Biotech B.V. & Co. KG
  • Proteintech Group, Inc.
  • BPS Bioscience, Inc.
  • RayBiotech Life, Inc.

The Global Recombinant Proteins Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period.

Recombinant proteins have a huge future in the study and development of cancer therapies. Examples of recombinant proteins used in cancer therapy research include growth factors, immunological checkpoints, and cell damage & oxidative stress proteins (preclinical stage). The utilization of recombinant proteins including immunological checkpoint, antibodies, and growth factors, for targeted purposes has risen as a result of a greater knowledge of neoplastic signalling cascades and the proteins involved in them.

Researchers utilise these proteins frequently to study how cancer signalling pathways and functions. Research uses recombinant immune checkpoints that directly target programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1), including PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2. Aside from that, proteins like CD40 Ligand/TRAP, CD226, and Human CellExp CTLA4/CD152 are often employed in studies on cancer therapy.

Growth in the business is predicted to be fueled by the increased incidence of chronic disorders such granulomatous disease, haemophilia, and sclerosis. Additionally, improved recombinant protein products, the growing preference for biologics and biosimilars, and other reasons all contribute to the industry's expansion. The race to discover cures and diagnostic tools for the SARS-CoV2 virus was fuelled by the COVID-19 epidemic.

With over 400 million people worldwide suffer from uncommon genetic illnesses, according to Global Genes. This figure demonstrates the urgent need for therapies, an improvement in healthcare environments, and increased public knowledge of health issues. A critical instrument for the creation of medicines is the requirement for cutting-edge research and knowledge of drug targeting mechanisms.

Cohort programmes have helped several regions create biobanks that give researchers access to high-quality samples that will revolutionise treatment efforts. This may lead to a greater emphasis on the identification of biomarkers for various illnesses. As an illustration, the FDA approved Ayvakit in August 2022 to address advanced systemic mastocytosis, a rare blood disorder.

COVID-19 Impact Analysis

The requirement for the COVID-19 vaccine to be developed quickly and on a large scale, as well as its ongoing commercial manufacturing activities, had a favourable effect on the development of biologics-based research initiatives and ultimately helped the industry's expansion. The COVID-19 pandemic had a favourable effect on the expansion of the proteins market. Recombinant protein vaccines may be developed with a combination of subunits of different adjuvants and antigens that will be more effective against SARS-CoV-2 infections and be readily available in the centre, it was suggested in light of the growth in COVID infection.

Market Growth Factors

Growing Emphasis On Customised Medicine Due To An Increase In The Prevalence Of Chronic Diseases

Recombinant proteins are one of the few recognised treatments for such conditions, and as chronic illnesses are on the rise, there is a significant demand for recombinant protein therapies. According to GLOBOCAN, there were estimated 195,499 new cancer cases and 90,222 cancer-related deaths in Mexico in 2020. Several biotechnologies, including vaccines, recombinant proteins, and cell and gene therapies, must be incorporated into the development of personalised medicine since they are essential to the personalization of care.

Increasing Biologics Research And Development

The market for recombinant proteins is anticipated to expand in demand due to the increased research and development on biologics. The R&D industry has traditionally required a lot of capital because of lengthy study periods and regulatory delays. Consumption on R&D accounts for a considerable share of global spending. Governments acknowledge R&D as a crucial factor in a nation's development, global competitiveness, and public good. R&D funding and spending have risen steadily as a result.

Market Restraining Factors

Recombinant proteins are getting cheaper.

Recombinant Proteins are made in labs using cells that have been grown, which contributes to their expensive price. Purification of these medications, which can make up as much as 80% of the manufacturing costs, is one of the major expenses. Price erosion is defined as when many players enter a particular market and sell identical products without any uniqueness, saturating the market with less creative and reasonably priced goods. Price erosion is the constant drop in the price of these products in a given market, which slows down market expansion.

Product Outlook

Based on Product, the market for recombinant proteins is classified into growth factors and chemokines, immune response proteins, structural proteins, membrane proteins, kinase proteins, regulatory proteins, recombinant metabolic enzymes, adhesion molecules and receptors, and other recombinant proteins. Immune response proteins are expected to command a sizable sales share in 2021. A crucial group of proteins in the body are cytokines. These little proteins act as immune system messengers. They serve as the immune system's network of communication and are created in reaction to a threat. Immune system cells can sometimes interact by touching one another directly, but more frequently, they do so via secreting cytokines, which can operate on other cells nearby or far away.

Application Outlook

Based on application, the market Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Diagnostics, and Other Applications. The biotechnology research command a significant revenue share in 2021. Recombinant proteins aid in illuminating an organism's basic and underlying principles. These molecules can be used to identify and pinpoint the location of the protein that a particular gene encodes, as well as to learn more about how other genes are involved in processes such as cell signalling, metabolism, growth, replication, and death, as well as translation, transcription, and protein modification.

End User Outlook

Based on End User, the Recombinant Proteins Market is divided in pharmaceutical and biopharmaceutical industry, biotechnology industry, academic research institutes, contract research organisations, and other end users. Contract Research Organizations are expected to account for a sizable portion of market revenue in 2021. The R&D industry saw increased investments in regards to partnerships and collaborations between academic institutions and businesses. For instance, the Center for Therapeutic Innovation (CTI) at Pfizer serves as a forum for interaction among stakeholders in the healthcare system.

Regional Outlook

Based on geography, the Recombinant Proteins Market is classified into North America, Europe, Asia Pacific, and LAMEA. The leading regional market for recombinant proteins in 2021 was North America. The high prevalence of chronic and genetic diseases, the availability of funding for R&D, government initiatives for R&D in the pharmaceutical industry, the growing use of life science techniques in research and academia, the significant presence of major pharmaceutical and biotechnology organizations, and the application of analytical instruments in drug discovery and development are all factors that contribute to North America holding a significant share of the global market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.

Strategies Deployed in Recombinant Proteins Market

Nov-2022: Abcam comes into agreement with NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research. Through this agreement, Abcam RabMAb™ recombinant antibodies would be produced as part of the first 64-plex protein panel for NanoString's CosMx™ Spatial Molecular Imager (SMI). Additionally, this agreement would open the full capability of spatial biology and help enhance care for people with cancer.

2022-Jul: Bio-Rad Laboratories launched EconoFit Columns, a low-pressure prepacked chromatography column pack. The EconoFit columns are created for resin screening, enabling customers that are designing protein purification workflows to choose the optimal chemistry for various targets. The products offer run-to-run uniformity to support preparative scale purifications and method advancement for the latest target proteins, as well as to improve existing workflows.

Feb-2022: Abcam came into agreement with Twist Bioscience Corporation, a synthetic biology company. Under this agreement, Abcam would use a proprietary Twist VHH phage library for antibody development, discovery, and commercialization for research and diagnostic application. Moreover, Twist Bioscience grants Abcam the right to perform research and development activities utilizing Twist single domain (VHH) synthetic antibody library.

Jan-2022: Thermo Fisher Scientific Inc. completed the acquisition PeproTech, Inc., a leading developer, and manufacturer of recombinant proteins. Through this acquisition, PeproTech's recombinant proteins suite aligns with Thermo Fisher's cell culture media products and would allow Thermo Fisher to offer customers significant advantages through an integrated offering.

2021-Nov: Abcam partnered with Nautilus Biotechnology, Inc., a development-stage life sciences company. Under this partnership, Both companies would focus on the combined advancement of affinity binding reagents used on the Nautilus proteomic analysis system and would broaden in the upcoming time to the large-scale manufacturing and supply of reagents for production.

Mar-2021: Bio-Techne Corporation released Cultrex™ UltiMatrix, a hydrogel extracellular matrix that is beneficial for cultivating pluripotent stem cells and organoids in terms of performance and consistency. The product develops Matriz hydrogels that support the growth use of pluripotent stem and organoid cells for drug research, commercialize medicine, and regenerative medicine.

Nov-2020: Merck signed an agreement with Donghao Lansheng (Group) Co., Ltd., a large modern service industry. This agreement would drive a new process that helps the custom clearing of research material for analytical use and biomedical innovation, through this Merck would be able to process shipments with the technical dossier and fewer application needs.

Nov-2019: Abcam plc announced a partnership with BrickBio, a Tiger Gene suite company and have specialization in site-specific protein modification. Through this partnership, Abcam would have full rights to the platform for the formation of novel conjugation-ready recombinant products for the research equipment market and to produce the platform over its recombinant antibody and protein offering for diagnostic use.

Apr-2019: Bio-Techne Corporation Collaborated with Elpiscience BioPharma, a clinical-stage biopharmaceutical company. Through this collaboration, both companies aimed to advance anti-cancer therapeutics and boost the development of the latest biologics to meet the medical requirements in Oncology.

Apr-2018: Proteintech Group acquired HumanZyme, a manufacturer of recombinant human proteins. Through this acquisition, the company would strengthen its place as a manufacturer of antibodies, ELISA kits, and proteins.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Growth Factors & Chemokines
  • Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
  • Structural Proteins
  • Membrane Proteins
  • Kinase Proteins & Regulatory Proteins
  • Immune Response Proteins
  • Others

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

By Application

  • Drug Discovery & Development
  • Academic Research Studies
  • Biopharmaceutical Production
  • Diagnostics
  • Biotechnology Research
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Bio-Techne Corporation
  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Bio-Rad Laboratories, Inc.
  • Abcam plc
  • Genscript Biotech Corporation
  • Miltenyi Biotec B.V. & Co. KG
  • Proteintech Group, Inc.
  • BPS Bioscience, Inc.
  • RayBiotech Life, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Recombinant Proteins Market, by Product
    • 1.4.2 Global Recombinant Proteins Market, by End User
    • 1.4.3 Global Recombinant Proteins Market, by Application
    • 1.4.4 Global Recombinant Proteins Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Recombinant Proteins Market

Chapter 4. Global Recombinant Proteins Market by Product

  • 4.1 Global Growth Factors & Chemokines Market by Region
  • 4.2 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region
  • 4.3 Global Structural Proteins Market by Region
  • 4.4 Global Membrane Proteins Market by Region
  • 4.5 Global Kinase Proteins & Regulatory Proteins Market by Region
  • 4.6 Global Immune Response Proteins Market by Region
  • 4.7 Global Others Market by Region

Chapter 5. Global Recombinant Proteins Market by End User

  • 5.1 Global Pharmaceutical & Biopharmaceutical Companies Market by Region
  • 5.2 Global Biotechnology Companies Market by Region
  • 5.3 Global Academic Research Institutes Market by Region
  • 5.4 Global Contract Research Organizations Market by Region
  • 5.5 Global Others Market by Region

Chapter 6. Global Recombinant Proteins Market by Application

  • 6.1 Global Drug Discovery & Development Market by Region
  • 6.2 Global Academic Research Studies Market by Region
  • 6.3 Global Biopharmaceutical Production Market by Region
  • 6.4 Global Diagnostics Market by Region
  • 6.5 Global Biotechnology Research Market by Region
  • 6.6 Global Others Market by Region

Chapter 7. Global Recombinant Proteins Market by Region

  • 7.1 North America Recombinant Proteins Market
    • 7.1.1 North America Recombinant Proteins Market by Product
      • 7.1.1.1 North America Growth Factors & Chemokines Market by Country
      • 7.1.1.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
      • 7.1.1.3 North America Structural Proteins Market by Country
      • 7.1.1.4 North America Membrane Proteins Market by Country
      • 7.1.1.5 North America Kinase Proteins & Regulatory Proteins Market by Country
      • 7.1.1.6 North America Immune Response Proteins Market by Country
      • 7.1.1.7 North America Others Market by Country
    • 7.1.2 North America Recombinant Proteins Market by End User
      • 7.1.2.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
      • 7.1.2.2 North America Biotechnology Companies Market by Country
      • 7.1.2.3 North America Academic Research Institutes Market by Country
      • 7.1.2.4 North America Contract Research Organizations Market by Country
      • 7.1.2.5 North America Others Market by Country
    • 7.1.3 North America Recombinant Proteins Market by Application
      • 7.1.3.1 North America Drug Discovery & Development Market by Country
      • 7.1.3.2 North America Academic Research Studies Market by Country
      • 7.1.3.3 North America Biopharmaceutical Production Market by Country
      • 7.1.3.4 North America Diagnostics Market by Country
      • 7.1.3.5 North America Biotechnology Research Market by Country
      • 7.1.3.6 North America Others Market by Country
    • 7.1.4 North America Recombinant Proteins Market by Country
      • 7.1.4.1 US Recombinant Proteins Market
        • 7.1.4.1.1 US Recombinant Proteins Market by Product
        • 7.1.4.1.2 US Recombinant Proteins Market by End User
        • 7.1.4.1.3 US Recombinant Proteins Market by Application
      • 7.1.4.2 Canada Recombinant Proteins Market
        • 7.1.4.2.1 Canada Recombinant Proteins Market by Product
        • 7.1.4.2.2 Canada Recombinant Proteins Market by End User
        • 7.1.4.2.3 Canada Recombinant Proteins Market by Application
      • 7.1.4.3 Mexico Recombinant Proteins Market
        • 7.1.4.3.1 Mexico Recombinant Proteins Market by Product
        • 7.1.4.3.2 Mexico Recombinant Proteins Market by End User
        • 7.1.4.3.3 Mexico Recombinant Proteins Market by Application
      • 7.1.4.4 Rest of North America Recombinant Proteins Market
        • 7.1.4.4.1 Rest of North America Recombinant Proteins Market by Product
        • 7.1.4.4.2 Rest of North America Recombinant Proteins Market by End User
        • 7.1.4.4.3 Rest of North America Recombinant Proteins Market by Application
  • 7.2 Europe Recombinant Proteins Market
    • 7.2.1 Europe Recombinant Proteins Market by Product
      • 7.2.1.1 Europe Growth Factors & Chemokines Market by Country
      • 7.2.1.2 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
      • 7.2.1.3 Europe Structural Proteins Market by Country
      • 7.2.1.4 Europe Membrane Proteins Market by Country
      • 7.2.1.5 Europe Kinase Proteins & Regulatory Proteins Market by Country
      • 7.2.1.6 Europe Immune Response Proteins Market by Country
      • 7.2.1.7 Europe Others Market by Country
    • 7.2.2 Europe Recombinant Proteins Market by End User
      • 7.2.2.1 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
      • 7.2.2.2 Europe Biotechnology Companies Market by Country
      • 7.2.2.3 Europe Academic Research Institutes Market by Country
      • 7.2.2.4 Europe Contract Research Organizations Market by Country
      • 7.2.2.5 Europe Others Market by Country
    • 7.2.3 Europe Recombinant Proteins Market by Application
      • 7.2.3.1 Europe Drug Discovery & Development Market by Country
      • 7.2.3.2 Europe Academic Research Studies Market by Country
      • 7.2.3.3 Europe Biopharmaceutical Production Market by Country
      • 7.2.3.4 Europe Diagnostics Market by Country
      • 7.2.3.5 Europe Biotechnology Research Market by Country
      • 7.2.3.6 Europe Others Market by Country
    • 7.2.4 Europe Recombinant Proteins Market by Country
      • 7.2.4.1 Germany Recombinant Proteins Market
        • 7.2.4.1.1 Germany Recombinant Proteins Market by Product
        • 7.2.4.1.2 Germany Recombinant Proteins Market by End User
        • 7.2.4.1.3 Germany Recombinant Proteins Market by Application
      • 7.2.4.2 UK Recombinant Proteins Market
        • 7.2.4.2.1 UK Recombinant Proteins Market by Product
        • 7.2.4.2.2 UK Recombinant Proteins Market by End User
        • 7.2.4.2.3 UK Recombinant Proteins Market by Application
      • 7.2.4.3 France Recombinant Proteins Market
        • 7.2.4.3.1 France Recombinant Proteins Market by Product
        • 7.2.4.3.2 France Recombinant Proteins Market by End User
        • 7.2.4.3.3 France Recombinant Proteins Market by Application
      • 7.2.4.4 Russia Recombinant Proteins Market
        • 7.2.4.4.1 Russia Recombinant Proteins Market by Product
        • 7.2.4.4.2 Russia Recombinant Proteins Market by End User
        • 7.2.4.4.3 Russia Recombinant Proteins Market by Application
      • 7.2.4.5 Spain Recombinant Proteins Market
        • 7.2.4.5.1 Spain Recombinant Proteins Market by Product
        • 7.2.4.5.2 Spain Recombinant Proteins Market by End User
        • 7.2.4.5.3 Spain Recombinant Proteins Market by Application
      • 7.2.4.6 Italy Recombinant Proteins Market
        • 7.2.4.6.1 Italy Recombinant Proteins Market by Product
        • 7.2.4.6.2 Italy Recombinant Proteins Market by End User
        • 7.2.4.6.3 Italy Recombinant Proteins Market by Application
      • 7.2.4.7 Rest of Europe Recombinant Proteins Market
        • 7.2.4.7.1 Rest of Europe Recombinant Proteins Market by Product
        • 7.2.4.7.2 Rest of Europe Recombinant Proteins Market by End User
        • 7.2.4.7.3 Rest of Europe Recombinant Proteins Market by Application
  • 7.3 Asia Pacific Recombinant Proteins Market
    • 7.3.1 Asia Pacific Recombinant Proteins Market by Product
      • 7.3.1.1 Asia Pacific Growth Factors & Chemokines Market by Country
      • 7.3.1.2 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
      • 7.3.1.3 Asia Pacific Structural Proteins Market by Country
      • 7.3.1.4 Asia Pacific Membrane Proteins Market by Country
      • 7.3.1.5 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country
      • 7.3.1.6 Asia Pacific Immune Response Proteins Market by Country
      • 7.3.1.7 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Recombinant Proteins Market by End User
      • 7.3.2.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country
      • 7.3.2.2 Asia Pacific Biotechnology Companies Market by Country
      • 7.3.2.3 Asia Pacific Academic Research Institutes Market by Country
      • 7.3.2.4 Asia Pacific Contract Research Organizations Market by Country
      • 7.3.2.5 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Recombinant Proteins Market by Application
      • 7.3.3.1 Asia Pacific Drug Discovery & Development Market by Country
      • 7.3.3.2 Asia Pacific Academic Research Studies Market by Country
      • 7.3.3.3 Asia Pacific Biopharmaceutical Production Market by Country
      • 7.3.3.4 Asia Pacific Diagnostics Market by Country
      • 7.3.3.5 Asia Pacific Biotechnology Research Market by Country
      • 7.3.3.6 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Recombinant Proteins Market by Country
      • 7.3.4.1 China Recombinant Proteins Market
        • 7.3.4.1.1 China Recombinant Proteins Market by Product
        • 7.3.4.1.2 China Recombinant Proteins Market by End User
        • 7.3.4.1.3 China Recombinant Proteins Market by Application
      • 7.3.4.2 Japan Recombinant Proteins Market
        • 7.3.4.2.1 Japan Recombinant Proteins Market by Product
        • 7.3.4.2.2 Japan Recombinant Proteins Market by End User
        • 7.3.4.2.3 Japan Recombinant Proteins Market by Application
      • 7.3.4.3 India Recombinant Proteins Market
        • 7.3.4.3.1 India Recombinant Proteins Market by Product
        • 7.3.4.3.2 India Recombinant Proteins Market by End User
        • 7.3.4.3.3 India Recombinant Proteins Market by Application
      • 7.3.4.4 South Korea Recombinant Proteins Market
        • 7.3.4.4.1 South Korea Recombinant Proteins Market by Product
        • 7.3.4.4.2 South Korea Recombinant Proteins Market by End User
        • 7.3.4.4.3 South Korea Recombinant Proteins Market by Application
      • 7.3.4.5 Singapore Recombinant Proteins Market
        • 7.3.4.5.1 Singapore Recombinant Proteins Market by Product
        • 7.3.4.5.2 Singapore Recombinant Proteins Market by End User
        • 7.3.4.5.3 Singapore Recombinant Proteins Market by Application
      • 7.3.4.6 Malaysia Recombinant Proteins Market
        • 7.3.4.6.1 Malaysia Recombinant Proteins Market by Product
        • 7.3.4.6.2 Malaysia Recombinant Proteins Market by End User
        • 7.3.4.6.3 Malaysia Recombinant Proteins Market by Application
      • 7.3.4.7 Rest of Asia Pacific Recombinant Proteins Market
        • 7.3.4.7.1 Rest of Asia Pacific Recombinant Proteins Market by Product
        • 7.3.4.7.2 Rest of Asia Pacific Recombinant Proteins Market by End User
        • 7.3.4.7.3 Rest of Asia Pacific Recombinant Proteins Market by Application
  • 7.4 LAMEA Recombinant Proteins Market
    • 7.4.1 LAMEA Recombinant Proteins Market by Product
      • 7.4.1.1 LAMEA Growth Factors & Chemokines Market by Country
      • 7.4.1.2 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
      • 7.4.1.3 LAMEA Structural Proteins Market by Country
      • 7.4.1.4 LAMEA Membrane Proteins Market by Country
      • 7.4.1.5 LAMEA Kinase Proteins & Regulatory Proteins Market by Country
      • 7.4.1.6 LAMEA Immune Response Proteins Market by Country
      • 7.4.1.7 LAMEA Others Market by Country
    • 7.4.2 LAMEA Recombinant Proteins Market by End User
      • 7.4.2.1 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country
      • 7.4.2.2 LAMEA Biotechnology Companies Market by Country
      • 7.4.2.3 LAMEA Academic Research Institutes Market by Country
      • 7.4.2.4 LAMEA Contract Research Organizations Market by Country
      • 7.4.2.5 LAMEA Others Market by Country
    • 7.4.3 LAMEA Recombinant Proteins Market by Application
      • 7.4.3.1 LAMEA Drug Discovery & Development Market by Country
      • 7.4.3.2 LAMEA Academic Research Studies Market by Country
      • 7.4.3.3 LAMEA Biopharmaceutical Production Market by Country
      • 7.4.3.4 LAMEA Diagnostics Market by Country
      • 7.4.3.5 LAMEA Biotechnology Research Market by Country
      • 7.4.3.6 LAMEA Others Market by Country
    • 7.4.4 LAMEA Recombinant Proteins Market by Country
      • 7.4.4.1 Brazil Recombinant Proteins Market
        • 7.4.4.1.1 Brazil Recombinant Proteins Market by Product
        • 7.4.4.1.2 Brazil Recombinant Proteins Market by End User
        • 7.4.4.1.3 Brazil Recombinant Proteins Market by Application
      • 7.4.4.2 Argentina Recombinant Proteins Market
        • 7.4.4.2.1 Argentina Recombinant Proteins Market by Product
        • 7.4.4.2.2 Argentina Recombinant Proteins Market by End User
        • 7.4.4.2.3 Argentina Recombinant Proteins Market by Application
      • 7.4.4.3 UAE Recombinant Proteins Market
        • 7.4.4.3.1 UAE Recombinant Proteins Market by Product
        • 7.4.4.3.2 UAE Recombinant Proteins Market by End User
        • 7.4.4.3.3 UAE Recombinant Proteins Market by Application
      • 7.4.4.4 Saudi Arabia Recombinant Proteins Market
        • 7.4.4.4.1 Saudi Arabia Recombinant Proteins Market by Product
        • 7.4.4.4.2 Saudi Arabia Recombinant Proteins Market by End User
        • 7.4.4.4.3 Saudi Arabia Recombinant Proteins Market by Application
      • 7.4.4.5 South Africa Recombinant Proteins Market
        • 7.4.4.5.1 South Africa Recombinant Proteins Market by Product
        • 7.4.4.5.2 South Africa Recombinant Proteins Market by End User
        • 7.4.4.5.3 South Africa Recombinant Proteins Market by Application
      • 7.4.4.6 Nigeria Recombinant Proteins Market
        • 7.4.4.6.1 Nigeria Recombinant Proteins Market by Product
        • 7.4.4.6.2 Nigeria Recombinant Proteins Market by End User
        • 7.4.4.6.3 Nigeria Recombinant Proteins Market by Application
      • 7.4.4.7 Rest of LAMEA Recombinant Proteins Market
        • 7.4.4.7.1 Rest of LAMEA Recombinant Proteins Market by Product
        • 7.4.4.7.2 Rest of LAMEA Recombinant Proteins Market by End User
        • 7.4.4.7.3 Rest of LAMEA Recombinant Proteins Market by Application

Chapter 8. Company Profiles

  • 8.1 Bio-Techne Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 Thermo Fisher Scientific, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Acquisition and Mergers:
  • 8.3 Merck Group
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
  • 8.4 Bio-Rad laboratories, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Product Launches and Product Expansions:
  • 8.5 Abcam plc
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 Genscript Biotech Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional & Segmental Analysis
    • 8.6.4 Research & Development Expenses
  • 8.7 Miltenyi Biotech B.V. & Co. KG
    • 8.7.1 Company Overview
  • 8.8 Proteintech Group, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Acquisition and Mergers:
  • 8.9 BPS Bioscience, Inc.
    • 8.9.1 Company Overview
  • 8.10. RayBiotech Life, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 2 Global Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 3 Global Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 4 Global Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 5 Global Growth Factors & Chemokines Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Growth Factors & Chemokines Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Structural Proteins Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Structural Proteins Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Membrane Proteins Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Membrane Proteins Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Kinase Proteins & Regulatory Proteins Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Kinase Proteins & Regulatory Proteins Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Immune Response Proteins Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Immune Response Proteins Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 20 Global Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 21 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Pharmaceutical & Biopharmaceutical Companies Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Biotechnology Companies Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Biotechnology Companies Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Academic Research Institutes Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Academic Research Institutes Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Contract Research Organizations Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Contract Research Organizations Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 32 Global Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 33 Global Drug Discovery & Development Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Drug Discovery & Development Market by Region, 2022 - 2028, USD Million
  • TABLE 35 Global Academic Research Studies Market by Region, 2018 - 2021, USD Million
  • TABLE 36 Global Academic Research Studies Market by Region, 2022 - 2028, USD Million
  • TABLE 37 Global Biopharmaceutical Production Market by Region, 2018 - 2021, USD Million
  • TABLE 38 Global Biopharmaceutical Production Market by Region, 2022 - 2028, USD Million
  • TABLE 39 Global Diagnostics Market by Region, 2018 - 2021, USD Million
  • TABLE 40 Global Diagnostics Market by Region, 2022 - 2028, USD Million
  • TABLE 41 Global Biotechnology Research Market by Region, 2018 - 2021, USD Million
  • TABLE 42 Global Biotechnology Research Market by Region, 2022 - 2028, USD Million
  • TABLE 43 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 44 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 45 Global Recombinant Proteins Market by Region, 2018 - 2021, USD Million
  • TABLE 46 Global Recombinant Proteins Market by Region, 2022 - 2028, USD Million
  • TABLE 47 North America Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 48 North America Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 49 North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 50 North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 51 North America Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Structural Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Structural Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Membrane Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Membrane Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 61 North America Immune Response Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Immune Response Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 66 North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 67 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 69 North America Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 70 North America Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 71 North America Academic Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 72 North America Academic Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 73 North America Contract Research Organizations Market by Country, 2018 - 2021, USD Million
  • TABLE 74 North America Contract Research Organizations Market by Country, 2022 - 2028, USD Million
  • TABLE 75 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 76 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 77 North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 78 North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 79 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 80 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 81 North America Academic Research Studies Market by Country, 2018 - 2021, USD Million
  • TABLE 82 North America Academic Research Studies Market by Country, 2022 - 2028, USD Million
  • TABLE 83 North America Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
  • TABLE 84 North America Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
  • TABLE 85 North America Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 86 North America Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 87 North America Biotechnology Research Market by Country, 2018 - 2021, USD Million
  • TABLE 88 North America Biotechnology Research Market by Country, 2022 - 2028, USD Million
  • TABLE 89 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 90 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 91 North America Recombinant Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 92 North America Recombinant Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 93 US Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 94 US Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 95 US Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 96 US Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 97 US Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 98 US Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 99 US Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 100 US Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 101 Canada Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 102 Canada Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 103 Canada Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 104 Canada Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 105 Canada Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 106 Canada Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 107 Canada Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 108 Canada Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 109 Mexico Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 110 Mexico Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 111 Mexico Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 112 Mexico Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 113 Mexico Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 114 Mexico Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 115 Mexico Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 116 Mexico Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 117 Rest of North America Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 118 Rest of North America Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 119 Rest of North America Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 120 Rest of North America Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 121 Rest of North America Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 122 Rest of North America Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 123 Rest of North America Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 124 Rest of North America Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 125 Europe Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 126 Europe Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 127 Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 128 Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 129 Europe Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Structural Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Structural Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Europe Membrane Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Europe Membrane Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Europe Immune Response Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Europe Immune Response Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 144 Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 145 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 146 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 147 Europe Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Europe Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Europe Academic Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 150 Europe Academic Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 151 Europe Contract Research Organizations Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Europe Contract Research Organizations Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 155 Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 156 Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 157 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 158 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 159 Europe Academic Research Studies Market by Country, 2018 - 2021, USD Million
  • TABLE 160 Europe Academic Research Studies Market by Country, 2022 - 2028, USD Million
  • TABLE 161 Europe Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
  • TABLE 162 Europe Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
  • TABLE 163 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 164 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 165 Europe Biotechnology Research Market by Country, 2018 - 2021, USD Million
  • TABLE 166 Europe Biotechnology Research Market by Country, 2022 - 2028, USD Million
  • TABLE 167 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 168 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 169 Europe Recombinant Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 170 Europe Recombinant Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 171 Germany Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 172 Germany Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 173 Germany Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 174 Germany Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 175 Germany Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 176 Germany Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 177 Germany Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 178 Germany Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 179 UK Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 180 UK Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 181 UK Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 182 UK Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 183 UK Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 184 UK Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 185 UK Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 186 UK Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 187 France Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 188 France Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 189 France Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 190 France Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 191 France Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 192 France Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 193 France Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 194 France Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 195 Russia Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 196 Russia Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 197 Russia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 198 Russia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 199 Russia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 200 Russia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 201 Russia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 202 Russia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 203 Spain Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 204 Spain Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 205 Spain Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 206 Spain Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 207 Spain Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 208 Spain Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 209 Spain Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 210 Spain Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 211 Italy Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 212 Italy Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 213 Italy Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 214 Italy Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 215 Italy Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 216 Italy Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 217 Italy Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 218 Italy Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 219 Rest of Europe Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 220 Rest of Europe Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 221 Rest of Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 222 Rest of Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 223 Rest of Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 224 Rest of Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 225 Rest of Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 226 Rest of Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 227 Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 228 Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 229 Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 230 Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 231 Asia Pacific Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
  • TABLE 232 Asia Pacific Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
  • TABLE 233 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
  • TABLE 234 Asia Pacific Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
  • TABLE 235 Asia Pacific Structural Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 236 Asia Pacific Structural Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 237 Asia Pacific Membrane Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 238 Asia Pacific Membrane Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 239 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 240 Asia Pacific Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 241 Asia Pacific Immune Response Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 242 Asia Pacific Immune Response Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 243 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 244 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 245 Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 246 Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 247 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 248 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 249 Asia Pacific Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 250 Asia Pacific Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 251 Asia Pacific Academic Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 252 Asia Pacific Academic Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 253 Asia Pacific Contract Research Organizations Market by Country, 2018 - 2021, USD Million
  • TABLE 254 Asia Pacific Contract Research Organizations Market by Country, 2022 - 2028, USD Million
  • TABLE 255 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 256 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 257 Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 258 Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 259 Asia Pacific Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 260 Asia Pacific Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 261 Asia Pacific Academic Research Studies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 Asia Pacific Academic Research Studies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 Asia Pacific Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
  • TABLE 264 Asia Pacific Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
  • TABLE 265 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 266 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 267 Asia Pacific Biotechnology Research Market by Country, 2018 - 2021, USD Million
  • TABLE 268 Asia Pacific Biotechnology Research Market by Country, 2022 - 2028, USD Million
  • TABLE 269 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 270 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 271 Asia Pacific Recombinant Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 272 Asia Pacific Recombinant Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 273 China Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 274 China Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 275 China Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 276 China Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 277 China Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 278 China Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 279 China Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 280 China Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 281 Japan Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 282 Japan Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 283 Japan Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 284 Japan Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 285 Japan Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 286 Japan Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 287 Japan Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 288 Japan Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 289 India Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 290 India Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 291 India Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 292 India Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 293 India Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 294 India Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 295 India Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 296 India Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 297 South Korea Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 298 South Korea Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 299 South Korea Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 300 South Korea Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 301 South Korea Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 302 South Korea Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 303 South Korea Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 304 South Korea Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 305 Singapore Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 306 Singapore Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 307 Singapore Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 308 Singapore Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 309 Singapore Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 310 Singapore Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 311 Singapore Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 312 Singapore Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 313 Malaysia Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 314 Malaysia Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 315 Malaysia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 316 Malaysia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 317 Malaysia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 318 Malaysia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 319 Malaysia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 320 Malaysia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 321 Rest of Asia Pacific Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 322 Rest of Asia Pacific Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 323 Rest of Asia Pacific Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 324 Rest of Asia Pacific Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 325 Rest of Asia Pacific Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 326 Rest of Asia Pacific Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 327 Rest of Asia Pacific Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 328 Rest of Asia Pacific Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 329 LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 330 LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 331 LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 332 LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 333 LAMEA Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
  • TABLE 334 LAMEA Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
  • TABLE 335 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
  • TABLE 336 LAMEA Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
  • TABLE 337 LAMEA Structural Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 338 LAMEA Structural Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 339 LAMEA Membrane Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 340 LAMEA Membrane Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 341 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 342 LAMEA Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 343 LAMEA Immune Response Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 344 LAMEA Immune Response Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 345 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 346 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 347 LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 348 LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 349 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 350 LAMEA Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 351 LAMEA Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 352 LAMEA Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 353 LAMEA Academic Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 354 LAMEA Academic Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 355 LAMEA Contract Research Organizations Market by Country, 2018 - 2021, USD Million
  • TABLE 356 LAMEA Contract Research Organizations Market by Country, 2022 - 2028, USD Million
  • TABLE 357 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 358 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 359 LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 360 LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 361 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 362 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 363 LAMEA Academic Research Studies Market by Country, 2018 - 2021, USD Million
  • TABLE 364 LAMEA Academic Research Studies Market by Country, 2022 - 2028, USD Million
  • TABLE 365 LAMEA Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
  • TABLE 366 LAMEA Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
  • TABLE 367 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 368 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 369 LAMEA Biotechnology Research Market by Country, 2018 - 2021, USD Million
  • TABLE 370 LAMEA Biotechnology Research Market by Country, 2022 - 2028, USD Million
  • TABLE 371 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 372 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 373 LAMEA Recombinant Proteins Market by Country, 2018 - 2021, USD Million
  • TABLE 374 LAMEA Recombinant Proteins Market by Country, 2022 - 2028, USD Million
  • TABLE 375 Brazil Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 376 Brazil Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 377 Brazil Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 378 Brazil Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 379 Brazil Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 380 Brazil Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 381 Brazil Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 382 Brazil Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 383 Argentina Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 384 Argentina Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 385 Argentina Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 386 Argentina Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 387 Argentina Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 388 Argentina Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 389 Argentina Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 390 Argentina Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 391 UAE Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 392 UAE Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 393 UAE Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 394 UAE Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 395 UAE Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 396 UAE Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 397 UAE Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 398 UAE Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 399 Saudi Arabia Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 400 Saudi Arabia Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 401 Saudi Arabia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 402 Saudi Arabia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 403 Saudi Arabia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 404 Saudi Arabia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 405 Saudi Arabia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 406 Saudi Arabia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 407 South Africa Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 408 South Africa Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 409 South Africa Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 410 South Africa Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 411 South Africa Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 412 South Africa Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 413 South Africa Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 414 South Africa Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 415 Nigeria Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 416 Nigeria Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 417 Nigeria Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 418 Nigeria Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 419 Nigeria Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 420 Nigeria Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 421 Nigeria Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 422 Nigeria Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 423 Rest of LAMEA Recombinant Proteins Market, 2018 - 2021, USD Million
  • TABLE 424 Rest of LAMEA Recombinant Proteins Market, 2022 - 2028, USD Million
  • TABLE 425 Rest of LAMEA Recombinant Proteins Market by Product, 2018 - 2021, USD Million
  • TABLE 426 Rest of LAMEA Recombinant Proteins Market by Product, 2022 - 2028, USD Million
  • TABLE 427 Rest of LAMEA Recombinant Proteins Market by End User, 2018 - 2021, USD Million
  • TABLE 428 Rest of LAMEA Recombinant Proteins Market by End User, 2022 - 2028, USD Million
  • TABLE 429 Rest of LAMEA Recombinant Proteins Market by Application, 2018 - 2021, USD Million
  • TABLE 430 Rest of LAMEA Recombinant Proteins Market by Application, 2022 - 2028, USD Million
  • TABLE 431 Key Information - Bio-Techne Corporation
  • TABLE 432 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 433 key Information - Merck GrouP
  • TABLE 434 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 435 key information - Abcam plc
  • TABLE 436 Key information - Genscript Biotech Corporation
  • TABLE 437 Key information - Miltenyi Biotec B.V. & Co. KG
  • TABLE 438 Key Information - Proteintech Group, Inc.
  • TABLE 439 Key Information - BPS Bioscience, Inc.
  • TABLE 440 Key Information - RayBiotech Life, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Recombinant Proteins Market share by Product, 2021
  • FIG 3 Global Recombinant Proteins Market share by Product, 2028
  • FIG 4 Global Recombinant Proteins Market by Product, 2018 - 2028, USD Million
  • FIG 5 Global Recombinant Proteins Market share by End User, 2021
  • FIG 6 Global Recombinant Proteins Market share by End User, 2028
  • FIG 7 Global Recombinant Proteins Market by End User, 2018 - 2028, USD Million
  • FIG 8 Global Recombinant Proteins Market share by Application, 2021
  • FIG 9 Global Recombinant Proteins Market share by Application, 2028
  • FIG 10 Global Recombinant Proteins Market by Application, 2018 - 2028, USD Million
  • FIG 11 Global Recombinant Proteins Market share by Region, 2021
  • FIG 12 Global Recombinant Proteins Market share by Region, 2028
  • FIG 13 Global Recombinant Proteins Market by Region, 2018 - 2028, USD Million